266 related articles for article (PubMed ID: 33548635)
1. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review.
Malafaia D; Albuquerque HMT; Silva AMS
Eur J Med Chem; 2021 Mar; 214():113209. PubMed ID: 33548635
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors.
Okuda M; Hijikuro I; Fujita Y; Teruya T; Kawakami H; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2016 Oct; 26(20):5024-5028. PubMed ID: 27624076
[TBL] [Abstract][Full Text] [Related]
3. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
Galdeano C; Viayna E; Sola I; Formosa X; Camps P; Badia A; Clos MV; Relat J; Ratia M; Bartolini M; Mancini F; Andrisano V; Salmona M; Minguillón C; González-Muñoz GC; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Muñoz-Torrero D
J Med Chem; 2012 Jan; 55(2):661-9. PubMed ID: 22185619
[TBL] [Abstract][Full Text] [Related]
4. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
Pont C; Ginex T; Griñán-Ferré C; Scheiner M; Mattellone A; Martínez N; Arce EM; Soriano-Fernández Y; Naldi M; De Simone A; Barenys M; Gómez-Catalán J; Pérez B; Sabate R; Andrisano V; Loza MI; Brea J; Bartolini M; Bolognesi ML; Decker M; Pallàs M; Luque FJ; Muñoz-Torrero D
Eur J Med Chem; 2021 Dec; 225():113779. PubMed ID: 34418785
[TBL] [Abstract][Full Text] [Related]
5. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
Ashrafian H; Zadeh EH; Khan RH
Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
[TBL] [Abstract][Full Text] [Related]
6. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Pérez-Areales FJ; Di Pietro O; Espargaró A; Vallverdú-Queralt A; Galdeano C; Ragusa IM; Viayna E; Guillou C; Clos MV; Pérez B; Sabaté R; Lamuela-Raventós RM; Luque FJ; Muñoz-Torrero D
Bioorg Med Chem; 2014 Oct; 22(19):5298-307. PubMed ID: 25156301
[TBL] [Abstract][Full Text] [Related]
7. Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment.
Mezeiova E; Hrabinova M; Hepnarova V; Jun D; Janockova J; Muckova L; Prchal L; Kristofikova Z; Kucera T; Gorecki L; Chalupova K; Kunes J; Hroudova J; Soukup O; Korabecny J
Bioorg Med Chem Lett; 2021 Jul; 43():128100. PubMed ID: 33984470
[TBL] [Abstract][Full Text] [Related]
8. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
[TBL] [Abstract][Full Text] [Related]
10. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.
Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation.
Lv P; Xia CL; Wang N; Liu ZQ; Huang ZS; Huang SL
Bioorg Med Chem; 2018 Sep; 26(16):4693-4705. PubMed ID: 30107970
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
13. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease.
Chioua M; Pérez-Peña J; García-Font N; Moraleda I; Iriepa I; Soriano E; Marco-Contelles J; Oset-Gasque MJ
Future Med Chem; 2015; 7(7):845-55. PubMed ID: 26061104
[TBL] [Abstract][Full Text] [Related]
14. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299
[TBL] [Abstract][Full Text] [Related]
15. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
16. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
[TBL] [Abstract][Full Text] [Related]
17. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
18. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
Ising C; Stanley M; Holtzman DM
Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
20. Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Alzheimers Dis; 2019; 72(s1):S145-S176. PubMed ID: 31594236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
